MétaCan
Menu
Retour à la cohorte
Enregistrement W4414740878 · doi:10.1093/clinchem/hvaf086.677

B-290 A perspective on commonly used drugs in patients receiving treatment for opioid use disorder in Ontario, Canada

2025· article· en· W4414740878 sur OpenAlexaffabout
Josko Ivica, Jacqueline Hudson, Matthew Nichols, Eleonora Petryayeva, Joseph Macri, Alannah McEvoy, M. Constantine Samaan

Notice bibliographique

RevueClinical Chemistry · 2025
Typearticle
Langueen
DomaineMedicine
ThématiqueOpioid Use Disorder Treatment
Établissements canadiensQueen's UniversityManitoba HealthLondon Health Sciences CentreMcMaster UniversityHamilton Health Sciences
Organismes subventionnairesnon disponible
Mots-clésBuprenorphineOpioid use disorderMethadoneOpiate Substitution TreatmentDemographicsOpioidDrugPerspective (graphical)

Résumé

récupéré en direct d'OpenAlex

Abstract Background Urine drug screens (UDS) are limited to a few drug classes of interest and are typically done by immunoassay-based (IA) methods. Screening results can then be confirmed by liquid chromatography coupled with tandem mass spectrometry methods (LC-MS/MS) if required. Medication-assisted treatment (MAT) has been used for treatment and monitoring of Opioid Use Disorders (OUD). Medications used in MAT are usually methadone and/or a combination of buprenorphine and naloxone. The aim of this is study was to see what other drugs the participants from the Pharmacogenetics of Opioid Substitution Treatment Response (POST) study in Ontario, Canada, were taking in addition to the prescribed medications. Methods Two hundred POST study participants provided their urine samples to be tested on LC-MS/MS after their urines had been screened by IA. There were 99 drugs tested in this method. The kits were provided by Chromsystems (Grafelfing, Germany) and we followed their procedure for the analysis of these drugs. We investigated the participants’ demographics by age and gender/sex, the most commonly used drugs, their most common combinations, and the number of participants who were taking = 2 drugs, confirmed by LC-MS/MS. We also checked discordances between IA and LC-MS/MS for MATs, and amphetamine and methamphetamine. All the analyses and pertaining graphs were done in Microsoft Excel (Microsoft Corporation). Results The average age for all participants was 39.5 years. The participants were divided into 5 age groups (20-29.9, 30-30.9, 40-49.9, 50-50.9, = 60) and two sexes (males and cis/trans-females). Majority (n=161, 80.5%) of the participants were of the European descent, and 43.0 % were females. The three most commonly abused drugs were selected for a more detailed demographics analysis: THC-COOH (n=96, 48%), amphetamine and methamphetamine (n=47, 23.5%, for both). THC-COOH was present in 11.5% participants aged 20-29.9, 16.5% aged 30-39.9, 10% aged 40-49.9, 8% aged 50-59.9 and 2% = 60 years of age. THC-COOH was present in 31.5% males and 16% females (0.5% trans-females). Both amphetamine and methamphetamine were present in 23.5% of the participants (n=47), and both were present in 15% males and 8.5% females, as expected. There was only a slight difference between age groups. The percentage of the most common drug combination was as follows: amphetamine and methamphetamine (42%); amphetamine, methamphetamine combined with THC-COOH (19%); and amphetamine, methamphetamine combined with norfentanyl (18%). The greatest number of participants who took = 2 drugs confirmed by LC-MS/MS (n=40, 20%) had 3 drugs in urine. Surprisingly, 26.5% of participants who were compliant with their MATs, confirmed by LC-MS/MS, were negative on IA screens. Thirty-one participants (15.5%) were falsely positive for either amphetamine or methamphetamine on IA, after being confirmed negative on LC-MS/MS. Conclusion This work has shed important light into what populations across Ontario, who are receiving MAT for OUD, concurrently use in addition to their prescribed treatment. It confirmed the importance of LC-MS/MS for confirmation of the compliance with MAT, as well as confirmation of commonly taken illicit drugs.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,001
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Commentaire · Signal consensuel: aucune
Score de désaccord entre enseignants0,050
Score d'incertitude au seuil0,362

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0000,001
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0020,005
Études des sciences et des technologies0,0040,001
Communication savante0,0010,001
Science ouverte0,0010,001
Intégrité de la recherche0,0010,001
Charge utile insuffisante (le modèle a refusé de juger)0,0160,001

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,026
Tête enseignante GPT0,335
Écart entre enseignants0,309 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueClinical ChemistryMême sujetOpioid Use Disorder TreatmentTravaux en français237 207